NTUS News and Press, Natus Medical Incorporated From 04/25/22

The largest deal announced last week was the acquisition of American Campus Communities (ACC) by Blackstone (BX) for nearly $13 billion. The deal represents a premium of 30% over the closing stock price of February 16, 2022, the date immediately prior to the company disclosing receipt...

NEW YORK, NY / ACCESSWIRE / April 20, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Vidler Water Resources, Inc. (NASDA...

Natus Medical Incorporated ( NASDAQ: NTUS ) shares are up 25% after the medical device solutions provider for screening, diagnosing and treating disorders that affect the brain sensory nervous systems ad neural pathways signed definitive agreement  to be bought by Arch...

Shares of Natus Medical (NASDAQ: NTUS) jumped 28.6% on Monday after the healthcare device maker struck a deal to be acquired by an affiliate of investment firm ArchiMed. The deal values Natus at roughly $1.2 billion. If completed, shareowners would receive $33.50 in cash for...

Gainers: Casa Systems (CASA) +67%. CEL-SCI Corporation (CVM) +55%. Natus Medical (NTUS) +29%. Frequency Therapeutics (FREQ) +26%. GWG Holdings (GWGH) +20%. IMARA (IMRA) +19%. Iveda Solutions (IVDA) +18%. AgriFORCE (AGRI) +18%. Maris-Tech (MTEK) +17%. Tritium DCFC (DCFC) +12%. Losers...

Gainers: Natus Medical (NTUS) +30%. MedAvail (MDVL) +25%. IMARA (IMRA) +13%. Frequency Therapeutics (FREQ) +11%. Lyra Therapeutics (LYRA) +4%. Losers: Nektar Therapeutics (NKTR) -36%. TG Therapeutics (TGTX) -24%. Lixte Biotechnology (LIXT) -15%.&#x...

Casa Systems (CASA) +41% as Verizon buys 9.9% stake. Natus Medical (NTUS) +28% to be acquired by Archimed Group for $33.50/share in cash or $1.2B. MedAvail Holdings (MDVL) +14%. IMARA (IMRA) +11%. Ocugen (OCGN) +7% on commercialization rights for COVID vaccine Co...

Natus Medical (NASDAQ:NTUS) to be acquired by an affiliate of ArchiMed, an investment firm focused exclusively on the healthcare industry for ~$1.2B. Shareholders will receive $33.50 in cash for each share of Natus (NTUS) common stock, representing a 29% premium to the closing price on April ...

Highlights : •        Transaction values Natus Medical, Incorporated at approximately $1.2 billion total equity value •        Pre-announces preliminary financial results for the first ...

PLEASANTON, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders...